Progyny (PGNY) Cost of Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Cost of Revenue data on file, last reported at $245.4 million in Q1 2026.

• On a quarterly basis, Cost of Revenue fell 1.13% year-over-year to $245.4 million in Q1 2026; TTM through Mar 2026 was $981.4 million, a 3.69% increase from a year earlier, with the FY2025 full-year figure at $984.2 million, up 7.69% from the prior year.
• Cost of Revenue for Q1 2026 stood at $245.4 million, up from $241.5 million in the prior quarter.
• Over the last five years, Cost of Revenue for PGNY reached as high as $253.9 million in Q2 2025 and fell as low as $139.3 million in Q1 2022.
• Historically, Cost of Revenue has averaged $212.5 million across 5 years, with a median of $218.7 million in 2023.
• Across the five-year window, Cost of Revenue surged 69.92% in 2022 and slipped 1.13% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $169.8 million in 2022, then advanced by 25.45% to $213.0 million in 2023, then climbed by 10.3% to $235.0 million in 2024, then grew by 2.78% to $241.5 million in 2025, then grew by 1.62% to $245.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $245.4 million in Q1 2026, $241.5 million in Q4 2025, and $240.5 million in Q3 2025.